The Placebo X Patent is for sale. We are the owners of a patent pending innovation that will revolutionise the healthcare industry. Our innovative process allows for the manufacturing of micro-doses of any drug, enabling the creation of a large variety of placebos. Whether in tablet, capsule, cream, injectable or patch format, our patent pending covers all medicines and in particular will be of interest to any pharmaceutical manufacturer producing generic medicines. We wish to sell the patent pending or partner with an organisation that can prosecute the patent in diverse geographical locations and bring the innovation to market. Discover the potential of Placebo X today.
At Placebo X, we are revolutionizing the way pharmaceutical products are created and prescribed. Our patent covers the development of ethically prescribable placebos, which can be manufactured in femtogram, attogram, or billion molecule formats, for instance. With our cutting-edge technology, we empower medical professionals to offer placebo-based treatments that meet ethical standards. Explore our range of products and services to discover the possibilities of placebo-based therapies.
Our patent-pending technology ensures that all placebos created by Placebo X meet ethical standards, offering a viable solution for patients who may not require active pharmaceutical ingredients.
In order to be ethically prescribed a placebo needs to be openly discussed with patients. Our innovation is to provide very small doses of pharmaceutical agents so that prescribers can state precisely what they contain. For instance a physician may provide zopiclone 3.75 attograms to patients with insomnia problems, or citalopram 20 attograms to patients with low mood, or 10 billion molecules of morphine to a patient who is in pain.
Placebo X provides a diverse selection of placebos for various pharmaceutical drugs, enabling healthcare professionals to tailor treatments to individual patients' needs. Our innovation triggers the placebo response rather than being a placebo outright, as it does contain some small drug amount. In attogram dosage a physician can provide a million people with daily tablet doses of any drug for a billion days ( or 2.73 million years) and yet still prescribe in total the same amount of drug in the milligram dose tablet.
Any drug can be formatted into a variety of placebo strengths to aid with physician management.
Any deliverable method is accounted for, be it tablet, capsule, cream, lotion, injectable, inhaler or skin patch. Healthy drinks and sport supplements are also feasible.
In primary care our placebo effect treatments will be avidly awaited by physicians who will be able to incorporate them quickly into their clinical guidelines and procedures.
The only ethically prescribable placebo currently available is that of homeopathy. Homeopathy though has an image problem, based as it is on using the cause of an ailment as a treatment agent, and using hypothetically infinite dilutions where no agent is present.Placebo X is at the forefront of innovation, driving advancements in placebo-based therapies. Our innovation addresses the negative image that homeopathy has, and brings an ethically prescribable placebo into the mainstream
For the first time, a placebo effect treatment option will be available that clinicians can use ethically in any clinical scenario and for any conventional drug therapy. Patients can receive the same drug but in such small doses that it will only act in a placebo format
The Placeo X patent pending is ‘UK Patent Pending No. 2217676.2
This has a deadline of November 2024 for submission of claims outside of the UK, ie for the USA Europe and the rest of the world.
To discuss purchasing this patent application in its current state, please contact me, Gary Rogers, at the message box below. Or alternatively at gary.rogers@placebox.co.uk
©Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details and accept the service to view the translations.